Press Releases

Current Articles | Categories | Search | Syndication

25 February 2015  Joanne Hunter
New four-way collaboration aims to improve clinical decision-making in the treatment of colon cancer
By Joanne Hunter @ 13:42 :: 15 Views

Greenville, South Carolina – 25th February 2015 – EKF Diagnostics subsidiary, Selah Genomics, has announced a major, four-way collaboration with Greenville Health System (GHS, South Carolina), DecisionQ Corporation (Virginia), and BD (Becton Dickinson and Company, New Jersey). Expected to last 18 months, the collaboration aims to unite classic clinical annotations with proprietary next generation sequencing (NGS) technology and artificial intelligence-based decision support algorithms in order to improve clinical decision support in the treatment of colon cancer patients. 

Read More

23 February 2015  Joanne Hunter
EKF introduces new diabetic biomarker test – The Stanbio Chemistry GSP LiquiColor® Assay
By Joanne Hunter @ 12:12 :: 38 Views

Cardiff, UK – 19th February 2015 – EKF Diagnostics, the global diagnostics company, announces that it has introduced a new diabetic biomarker test that provides a 2-3 week indicator of average blood glucose. The Stanbio Chemistry Glycated Serum Protein (GSP) LiquiColor® test closes the information gap between daily blood glucose testing and the 2-3 month HbA1c reading. This means that GSP serves as an accurate intermediate marker of glycemia in instances where HbA1c may be of limited value, such as pregnancy, reduced RBC lifespan and hemodialysis.1

Read More

17 February 2015  Joanne Hunter
Siemens Healthcare partners with UK’s leading medical supplier in primary care
By Joanne Hunter @ 08:33 :: 97 Views


Siemens Healthcare have partnered with Williams Medical Supplies to bring innovation to point of care testing in primary care. Williams, part of the DCC Vital group of companies, is a leading provider of medical equipment and services to the UK healthcare market. The partnership of core company values and responsible business practice presents a robust and dependable offering to GPs, nurses and other healthcare professionals.

Read More

13 February 2015  Joanne Hunter
FABPulous BV closes Series B Funding; Begins commercial activities with rapid 5-minute point-of-care IVD for H-FABP
By Joanne Hunter @ 09:47 :: 114 Views

The funds will allow the commercialization of the patented and CE-marked H-FABP True Rapid Test ® for exclusion of acute myocardial infarction (AMI) in risk stratification of patients at primary care and emergency medicine.
Read More

13 February 2015  Joanne Hunter
Randox Puts Health in the Frontline as Winner In Prestigious European Business Awards
By Joanne Hunter @ 08:35 :: 114 Views

Leading clinical diagnostics company Randox is delighted to have been selected as a ‘Ruban D’Honneur’ winner for imports/exports in the prestigious European Business Awards 2014/15.

Read More

05 February 2015  Joanne Hunter
NEW £20 BLOOD TEST A BREAKTHROUGH IN THE DIAGNOSIS OF BOWEL CANCER
By Joanne Hunter @ 09:02 :: 145 Views




·         New blood test will spot bowel cancer at earliest stage

·         Simple check will ID cancer missed by existing screening

·         No need for ‘unpleasant’ faecal screen

·         1-in-20 people in UK will develop bowel cancer

 

British and Irish scientists are developing a new £20 blood test for bowel cancer, which could save thousands of lives by spotting the disease at the earliest possible opportunity. The simple check will pick up on antibodies in the blood, produced as the body reacts to the onset of bowel cancer.

Read More

03 February 2015  Joanne Hunter
Proteome Sciences extends its reach through collaboration with MedBiomix Partners
By Joanne Hunter @ 09:18 :: 113 Views

Cobham, Surrey; 3rd Feb 2015. MedBiomix Partners SAS and Proteome Sciences Ltd are proud to announce they enter into a collaborative network alliance, whose goal is to provide healthcare professionals with advanced data-driven solutions to integrate and make better use of protein expression data that will significantly improve the life and disease conditions of their patients.

Read More

16 January 2015  Rebecca Bellars
UroSens Receives £2 Million Investment to Commercialise Urine-Based Diagnostic Test for Bladder and Prostate Cancer
By Rebecca Bellars @ 12:05 :: 208 Views



Cambridge and Sunderland, UK, 12 January 2015:
UroSens Ltd, a diagnostic company developing novel, non-invasive urine tests for the detection of prostate and bladder cancer, has announced it has received £2 million ($3.02 million) investment. The funding round was led by Longwall Venture Partners, with participation from shareholders including Northstar Ventures, Esperante BV, Cambridge Capital Group and other existing shareholders. 

Read More

15 January 2015  Joanne Hunter
EKF highlighting heat and humidity compatible POC hemoglobin analyzer at Arab Health 2015
By Joanne Hunter @ 16:13 :: 177 Views

Cardiff, UK – 15th January 2015 – EKF Diagnostics, the global diagnostics company, announces that it will be highlighting the robustness of its new DiaSpect Tm point of care (POC) hemoglobin analyzer at Arab Health 2015, 26-29th January, Dubai, UAE. Also on Stand Z1G30, EKF will be discussing its new liquid-stable assay* for early sepsis detection, as well as previewing SensPoint, a new hand-held lactate analyzer with built-in connectivity functions to hospital or laboratory information systems.

Read More

15 January 2015  Joanne Hunter
Randox puts British Biotechnology on World Map with New Randox Science Park
By Joanne Hunter @ 08:48 :: 176 Views


  • £161m investment including £29m capital project and creation of 540 jobs
  • Next generation medical diagnostics manufacturing facility
  • World leading R&D into conditions such as cancer, stroke, heart disease, neurodegenerative disorders, sepsis, STIs, aspirin resistance and respiratory infections

“This investment and expansion reinforces our dedication to improving health worldwide…”

Read More

Previous Page | Next Page